MEDBOX | category Clinical Guidelines

Neisseria gonorrhoeae Antimicrobial Resistance Surveillance: Consolidated Guidance

World Health Organization WHO (2020) C_WHO

Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas, the high burden of new N. gonorrhoeae infections (estimated at 11 million new cases a year), the complexity of the disease epidemiology, and in many countries the limited resources, make it difficult to fully understand the burden of disease and the burden of antimicrobial resistance (AMR) in N. gonorrhoeae. PAHO has developed this document to facilitate the navigation of available guidance and recommendations for N. gonorrhoeae AMR surveillance by public health and health care professionals, at the national and subnational levels, involved in designing, implementing, and/or strengthening AMR surveillance of N. gonorrhoeae and overall surveillance of sexually transmitted infections

Tags: Latin America, Sexually transmitted infections (STIs), AMR, neisseria,

Source: https://iris.paho.org/handle/10665.2/523

World Health Organization WHO (2020) C_WHO

The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment provides practical guidance on how to put in place the recommendations at the scale needed to achieve national and global impact. The operational handbook provides practical information and tools that complement the recommendations in the guidelines. The strategies described in the operational handbook are based on the latest WHO recommendations which were formulated by Guideline Development Groups using the GRADE approach. In many cases however, the recommendations in their current form lacked sufficient clinical and programmatic detail, which is important for implementation. This operational handbook complements the guidelines with practical advice based on best practices and knowledge from the fields such as pharmacokinetics, pharmacodynamics, microbiology, pharmacovigilance and clinical and programmatic management

Tags: TB, Tuberculosis, MDR-TB, Multi-drugresistant Tuberculosis/MDR-TB, guideline,

Source: https://apps.who.int/iris/rest/bitstream

Managing People with Hypertension and Cardiovascular Disease during COVID-19: Considerations for Health Providers, 3 June 2020

Pan American Health Organisation PAHO (2020) C_WHO

Primary care health centers and providers who care for individuals with hypertension and cardiovascular disease have an important role to play in ensuring continued access to care, reducing the risk of coronavirus infection, and appropriately managing people with these co-morbidities who acquire COVID-19. This guidance includes these consideration

Tags: COVID-19, Cardiovascular Disease, hypertension, NCD, Noncommunicable diseases (NCDs), primary care, risk factors,

Source: https://iris.paho.org/handle/10665.2/522

Drug-resistant tuberculosis: how to interpret rapid molecular test results

World Health Organisation (2020) C_WHO

This training toolkit by the European Laboratory Initiative for TB, HIV and Viral Hepatitis provides a unique combination of practical guidance and expert advice on the interpretation of selected WHO-endorsed tests for drug-resistant tuberculosis (DR-TB)

Tags: Tuberculosis, Drug Resistance, Multidrug resistant tuberculosis,

Source: https://openwho.org/courses/multi-drug-r

Lignes directrices pour les essais en laboratoire et sur le terrain de molluscicides destinés à la lutte contre la schistosomiase

Organisation Mondiale de la Santé OMS (2020) C_WHO

Tags: Schistosomiasis, molluscicides, laboratoire,

Source: https://apps.who.int/iris/bitstream/hand

HEARTS D: diagnosis and management of type 2 diabetes

World Health Organization WHO (2020) C_WHO

Tags: Diabetes, diabetes type 2, NCD, Noncommunicable Diseases,

Source: https://apps.who.int/iris/bitstream/hand

World Health Organization WHO (2020) C1

To save the lives of mothers and their babies, mitigate complications, and limit the spread of disease, it is critical that recommendations are made on the prevention, treatment, and surveillance of women who are exposed to EVD, acquire EVD during pregnancy or breastfeeding, or survive EVD with ongoing pregnancies. These guidelines are the first to provide such recommendations

Tags: pregnant women, Breastfeeding, Ebola,

Source: https://www.who.int/reproductivehealth/p

Statistics: HIV/AIDS (UNAIDS)

UNAIDS, AIDSinfo (2020) C2

Accessed on 28.02.2020

Tags: Senegal, statistics, AIDS, new infections, Epidemiology, mother to child transmission, HIV,

Source: http://aidsinfo.unaids.org/

WHO report on cancer: setting priorities, investing wisely and providing care for all

World Health Organization WHO (2020) C1

Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key to success, according to this report. In 2019, over 90% of high-income countries reported that comprehensive cancer treatment services were available through the public health system, compared to fewer than 15% of low-income countries, according to WHO. But poorer countries can make substantial strides with a universal health coverage approach and use of the latest science to meet their particular needs. The report lays out proven ways to prevent new cancer cases without breaking the bank, including tobacco-control measures and vaccines that protect against common cancers

Tags: cancer, Report,

Source: https://apps.who.int/iris/rest/bitstream

Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States

Development of Health and Human Services USA; AIDSinfo Development of Health and Human Services USA; AIDSinfo (2020) C2

Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission— A Working Group of the Office of AIDS Research Advisory Council (OARAC) Accessed: 12.02.202

Tags: HIV, pregnant women, drugs, interventions, antiretrovirals,

Source: https://aidsinfo.nih.gov/contentfiles/lv

	Neisseria gonorrhoeae Antimicrobial Resistance Surveillance: Consolidated Guidance World Health Organization WHO (2020) C_WHO View PDF(1) Download (0) Add to my MEDBOX Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas, the high burden of new N. gonorrhoeae infections (estimated at 11 million new cases a year), the complexity of the disease epidemiology, and in many countries the limited resources, make it difficult to fully understand the burden of disease and the burden of antimicrobial resistance (AMR) in N. gonorrhoeae. PAHO has developed this document to facilitate the navigation of available guidance and recommendations for N. gonorrhoeae AMR surveillance by public health and health care professionals, at the national and subnational levels, involved in designing, implementing, and/or strengthening AMR surveillance of N. gonorrhoeae and overall surveillance of sexually transmitted infections Tags: Latin America, Sexually transmitted infections (STIs), AMR, neisseria, Source: https://iris.paho.org/handle/10665.2/523
	WHO Operational Handbook on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment World Health Organization WHO (2020) C_WHO View PDF(1) Download (0) Add to my MEDBOX The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment provides practical guidance on how to put in place the recommendations at the scale needed to achieve national and global impact. The operational handbook provides practical information and tools that complement the recommendations in the guidelines. The strategies described in the operational handbook are based on the latest WHO recommendations which were formulated by Guideline Development Groups using the GRADE approach. In many cases however, the recommendations in their current form lacked sufficient clinical and programmatic detail, which is important for implementation. This operational handbook complements the guidelines with practical advice based on best practices and knowledge from the fields such as pharmacokinetics, pharmacodynamics, microbiology, pharmacovigilance and clinical and programmatic management Tags: TB, Tuberculosis, MDR-TB, Multi-drugresistant Tuberculosis/MDR-TB, guideline, Source: https://apps.who.int/iris/rest/bitstream
	Managing People with Hypertension and Cardiovascular Disease during COVID-19: Considerations for Health Providers, 3 June 2020 Pan American Health Organisation PAHO (2020) C_WHO View PDF(5) Download (1) Add to my MEDBOX Primary care health centers and providers who care for individuals with hypertension and cardiovascular disease have an important role to play in ensuring continued access to care, reducing the risk of coronavirus infection, and appropriately managing people with these co-morbidities who acquire COVID-19. This guidance includes these consideration Tags: COVID-19, Cardiovascular Disease, hypertension, NCD, Noncommunicable diseases (NCDs), primary care, risk factors, Source: https://iris.paho.org/handle/10665.2/522
	Drug-resistant tuberculosis: how to interpret rapid molecular test results World Health Organisation (2020) C_WHO Open external link (56) Add to my MEDBOX This training toolkit by the European Laboratory Initiative for TB, HIV and Viral Hepatitis provides a unique combination of practical guidance and expert advice on the interpretation of selected WHO-endorsed tests for drug-resistant tuberculosis (DR-TB) Tags: Tuberculosis, Drug Resistance, Multidrug resistant tuberculosis, Source: https://openwho.org/courses/multi-drug-r
	Lignes directrices pour les essais en laboratoire et sur le terrain de molluscicides destinés à la lutte contre la schistosomiase Organisation Mondiale de la Santé OMS (2020) C_WHO View PDF(0) Download (0) Add to my MEDBOX Tags: Schistosomiasis, molluscicides, laboratoire, Source: https://apps.who.int/iris/bitstream/hand
	HEARTS D: diagnosis and management of type 2 diabetes World Health Organization WHO (2020) C_WHO View PDF(5) Download (7) Add to my MEDBOX Tags: Diabetes, diabetes type 2, NCD, Noncommunicable Diseases, Source: https://apps.who.int/iris/bitstream/hand
	Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease World Health Organization WHO (2020) C1 View PDF(25) Download (20) Add to my MEDBOX To save the lives of mothers and their babies, mitigate complications, and limit the spread of disease, it is critical that recommendations are made on the prevention, treatment, and surveillance of women who are exposed to EVD, acquire EVD during pregnancy or breastfeeding, or survive EVD with ongoing pregnancies. These guidelines are the first to provide such recommendations Tags: pregnant women, Breastfeeding, Ebola, Source: https://www.who.int/reproductivehealth/p
	Statistics: HIV/AIDS (UNAIDS) UNAIDS, AIDSinfo (2020) C2 View PDF(7) Download (9) Add to my MEDBOX Accessed on 28.02.2020 Tags: Senegal, statistics, AIDS, new infections, Epidemiology, mother to child transmission, HIV, Source: http://aidsinfo.unaids.org/
	WHO report on cancer: setting priorities, investing wisely and providing care for all World Health Organization WHO (2020) C1 View PDF(12) Download (15) Add to my MEDBOX Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key to success, according to this report. In 2019, over 90% of high-income countries reported that comprehensive cancer treatment services were available through the public health system, compared to fewer than 15% of low-income countries, according to WHO. But poorer countries can make substantial strides with a universal health coverage approach and use of the latest science to meet their particular needs. The report lays out proven ways to prevent new cancer cases without breaking the bank, including tobacco-control measures and vaccines that protect against common cancers Tags: cancer, Report, Source: https://apps.who.int/iris/rest/bitstream
	Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States Development of Health and Human Services USA; AIDSinfo Development of Health and Human Services USA; AIDSinfo (2020) C2 View PDF(15) Download (25) Add to my MEDBOX Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission— A Working Group of the Office of AIDS Research Advisory Council (OARAC) Accessed: 12.02.202 Tags: HIV, pregnant women, drugs, interventions, antiretrovirals, Source: https://aidsinfo.nih.gov/contentfiles/lv

WHO Operational Handbook on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment (2020)

Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease (2020)

Consolidated guidelines on HIV testing services for a changing epidemic (2019)

MSF Guide clinique et thérapeutique (2019)

MSF Clinical Guidelines. Diagnosis and Treatment Manual (2019)

Managing People with Hypertension and Cardiovascular Disease during COVID-19: Considerations for Health Providers, 3 June 2020 (2020)

WHO Operational Handbook on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment (2020)

Neisseria gonorrhoeae Antimicrobial Resistance Surveillance: Consolidated Guidance (2020)

Drug-resistant tuberculosis: how to interpret rapid molecular test results (2020)

Lignes directrices pour les essais en laboratoire et sur le terrain de molluscicides destinés à la lutte contre la schistosomiase (2020)

About MEDBOX

WHO Operational Handbook on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment (2020)

Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease (2020)

Consolidated guidelines on HIV testing services for a changing epidemic (2019)

MSF Guide clinique et thérapeutique (2019)

MSF Clinical Guidelines. Diagnosis and Treatment Manual (2019)

Managing People with Hypertension and Cardiovascular Disease during COVID-19: Considerations for Health Providers, 3 June 2020 (2020)

WHO Operational Handbook on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment (2020)

Neisseria gonorrhoeae Antimicrobial Resistance Surveillance: Consolidated Guidance (2020)

Drug-resistant tuberculosis: how to interpret rapid molecular test results (2020)

Lignes directrices pour les essais en laboratoire et sur le terrain de molluscicides destinés à la lutte contre la schistosomiase (2020)